Helus Pharma has revealed data from a phase 3 trial of HLP003 that showed evidence of efficacy in major depressive disorder ...
New Orleans hosted this year’s AAPS PharmSci 360 at the Ernest N. Morial Convention Center. For those fortunate enough to ...
AstraZeneca's rare disease unit Alexion has won regulatory approval in the US and EU for Klygefa as a generalised myasthenia ...
Eli Lilly has added yet another name to its list of M&A deals this year after agreeing to buy blood disorder specialist Calytrix Bio for up to $1.5 billion. If it goes through, the deal will give ...
China has overtaken Europe as the preferred location for healthcare investing, according to a new report from Jefferies, published as the investment group's global conference gets underway in London ...
The FDA has said it cannot approve Summit Therapeutics and Akeso's PD-1xVEGF inhibitor ivonescimab, delaying a drug that is ...
Berkeley Heights, NJ – April 15, 2026: Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced the acquisition of Conexus Solutions, a premier ...
Eledon Pharmaceuticals has revealed that two patients with type 1 diabetes achieved a 'functional cure' after receiving a transplant of insulin-producing islet cells in combination with its ...
Hims & Hers is also offering compounded formulations of other unapproved peptides, including sermorelin, which some people ...
The takeover deal – worth up to $1.15 billion including $550 million in upfront cash – will upgrade the Dutch biotech's ...
Just a few months after being formed, China's Funnel Biosciences has signed a $2 billion-plus partnership with Third Rock ...
Patients with muscle-invasive bladder cancer can now receive NHS treatment with a regimen of MSD's Keytruda and Astellas' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results